Home » Areas of Work » Intellectual Property » Patent Law Harmonization

Patent Law Harmonization

IP: Imperative for Innovation
March 29, 2011

Patent systems can provide an advantage to society by rewarding the development of new...

More Articles →

Letters, Testimony & Comments

BIO Submits Comments on Brazil Rare Diseases Public Consultation
June 7 2013
BIO applauds the government of Brazil for taking steps towards developing regulatory requirements to ensure patients suffering from rare diseases have access to treatment.   
BIO Comments on Peruvian Biologics and Biosimilars Regulations
March 21 2013
BIO commends the Government of Peru for its endeavor to create a pathway for the approval of biological and biotechnological products. Peru is a growing market for biotechnology products and with the implementation of the US-Peru TPA, it promises to become an even bigger market.
BIO Comments on Colombia Biologics and Biosimilars Regulations
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of biological origin. Many elements of the third draft appear to have addressed BIO's previous comments with respect to clarity of structure and definitions of terms, as well as expectations for data requirements.   
BIO Comments on INPI Guidelines for Examination of Biotechnology Patent Applications in Brazil
February 1 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological advances and the innovation that spurs it are the primary drivers of economic growth in the modern era, it is critical that patent laws and practices properly motivate and reward innovation.
International Patent Issues Highlighted at House Judiciary Committee Hearing: BIO Submits Biotech's Challenges
April 26 2012
More Letters, Testimony & Comments →

Press Releases

Statement On U.S. Supreme Court Review Of Isolated DNA Patents
June 13 2013
The SCOTUS decision represents a departure from judicial and PTO precedent supporting patentability of DNA molecules. The decision could create business uncertainty for a range of inventions.
BIO Hosts U.S./China Biotechnology Examiner Workshop with U.S. Patent and Trademark Office and China’s State Intellectual Property Office
April 5 2011
The Biotechnology Industry Organization (BIO) hosted a U.S./China Biotechnology Examiner Workshop with U.S. Patent and Trademark Office (PTO) and China's State Intellectual Property Office (SIPO) on March 28, 2011 in Beijing, China.
Director of U.S. Patent and Trademark Office to Speak at 2010 BIO International Convention
March 15 2010
David Kappos, Director of the U.S. Patent and Trademark Office and Under Secretary of Commerce for Intellectual Property, will be a featured speaker at the Intellectual Property Super Session taking place during the 2010 BIO International Convention.